Verified peer comparison
Xeris Biopharma Holdings vs Katapult Holdings Financial Comparison
Direct answer
Xeris Biopharma Holdings and Katapult Holdings are compared on the same basis.
The comparison uses 2025 results reported in USD.
Common metrics include Revenue, Operating income, Net income, Operating cash flow.
Alpha Vantage
Get free Xeris Biopharma Holdings email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Xeris Biopharma Holdings Revenue
- 291,845,000 USD
- Katapult Holdings Revenue
- 291,761,000 USD
- Xeris Biopharma Holdings Operating income
- 24,896,000 USD
- Katapult Holdings Operating income
- 300,000 USD